1. Home
  2. AKBA vs ISSC Comparison

AKBA vs ISSC Comparison

Compare AKBA & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.38

Market Cap

380.4M

Sector

Health Care

ML Signal

HOLD

Logo Innovative Solutions and Support Inc.

ISSC

Innovative Solutions and Support Inc.

HOLD

Current Price

$26.01

Market Cap

380.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
ISSC
Founded
2007
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
380.4M
380.6M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
AKBA
ISSC
Price
$1.38
$26.01
Analyst Decision
Strong Buy
Buy
Analyst Count
6
1
Target Price
$5.75
$16.50
AVG Volume (30 Days)
2.5M
642.2K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
93.94
120.00
EPS
N/A
0.22
Revenue
N/A
N/A
Revenue This Year
N/A
$6.63
Revenue Next Year
N/A
$8.13
P/E Ratio
N/A
$124.18
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$5.30
52 Week High
$4.08
$30.98

Technical Indicators

Market Signals
Indicator
AKBA
ISSC
Relative Strength Index (RSI) 51.06 47.64
Support Level $1.30 $17.57
Resistance Level $1.55 $30.98
Average True Range (ATR) 0.07 2.17
MACD 0.00 -0.53
Stochastic Oscillator 50.70 10.22

Price Performance

Historical Comparison
AKBA
ISSC

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: